Homocysteine – a new arteriosclerotic risk factor in end-stage renal failure

Nephron

Volumn 75, Issue 3, 1997, Pages 249-250

  Zidek, W ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; HOMOCYSTEINE;

AMINO ACID METABOLISM; ARTERIOSCLEROSIS; EDITORIAL; HUMAN; KIDNEY FAILURE; PRIORITY JOURNAL; RISK FACTOR;

ARTERIOSCLEROSIS; CYSTATHIONINE BETA-SYNTHASE; FOLIC ACID; HOMOCYSTEINE; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; RISK FACTORS;

EID: 0031038722     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000189544     Document Type: Article

References (20)

1. Carson NAJ. Neill DW: Metabolic abnormalities detected in a survey of mentally backward individuals in Northern Ireland. Arch Dis Child 1962:37:505-513.
2. Finkelstein JD: Methionine metabolism in mammals: The biochemical basis for homocys-tinuria. Metabolism 1974;23:387-398.
3. Gupta VJ. Wilckcn DHL: The detection of cys-tcine-homocysteine mixed disulphide in plasma of normal fasting man. Eur J Clin invest 1978:8:205-207.
4. Molgaard J. Malinow MR. Lassvik C, Holm A-C. Upson B, Olsson AG: Hyperhomocyst(e)i-naemia: An independent risk factor for intermittent claudication. J Intern Med 1992:231: 273-279.
5. Clarke R. Daly L. Robinson K. et al: Hyperho-mocysteincmia: An independent risk factor for vascular disease. N Engl J Med 1991;324: 1149-1155.
6. Selhub J. Jacques PF. Bostom AG. D'Agostino RB. Wilson PWF. Belanger AJ. O’Leary DH. Wolf PA, Schaefer EJ. Rosenberg IH: Association between plasma homocysteine concentrations and extracranial carotid artery stenosis. N Engl J Med 1995;332:286-291.
7. Glueck CJ, Shaw P. Lang JE, Tracy T, Sieve-Smith L. Wang Y: Evidence that homocysteine is an independent risk factor for atherosclerosis in hyperlipidémie patients. Am J Cardiol 1995; 75:132-136.
8. Stampfer MJ. Malinow MR. Willett WC. Newcomer LM, Upson B. Ullmann D. Tishler PV. Hcnnckens CH: A prospective study of plasma homocyst(c)inc and risk of myocardial infarction in US phvsicians. JAMA 1992:268:877-881.
9. Ubbink JB. Vermaak WJH. Bennett JM. Becker PJ. van Staden DA. Bissbort S: The prevalence of homocystcincmia and hypercholesterolemia in angiographically defined coronary heart disease. Klin Wochenschr 1991;69:527-534.
10. Brattstrôm L. Lindgren A: Hyperhomocvstei-nemia as a risk factor for stroke. Neurol Res 1992:14(suppl 2):81-84.
11. Brattstrôm L, Lindgren A. Israclsson B. Malinow MR. Norrving B, Upson B. Hamfelt A: Hypcrhomocysteinaemia in stroke: Prevalence, cause, and relationships to type of stroke and stroke risk factors. Eur J Clin Invest 1992; 22:214-221.
12. Wilckcn DEL, Gupta VJ: Sulphur-containing amino acids in chronic renal failure with particular reference to homocysteine and cvsteine-homocystcine mixed disulphide. Eur J Clin Invest 1979;9:301-307.
13. Ueland PM. Refsum H: Plasma homocysteine, a risk factor for vascular disease: Plasma levels in health, disease, and drug therapy. J Lab Clin Med 1989;114:473-501.
14. Dudman NPB, Tyrrell PA, Wilckcn DEL: Ho mocystcinemia: Depressed plasma serine levels. Metabolism 1987;36:198-202.
15. Bostom AG. Shcrnin D, Lapane KL. Miller JW, Sutherland P. Nadeau M, Seyoum E, Hartman W. Prior R, Wilson PW, et al: Hyperho-mocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: A case-control study. Atherosclerosis 1995; 114:93-103.
16. Bachmann J. Tepe IM. Raidt H. Riezler R, Graefe U. Langcr K. Zidek W: Hyperhomocys-teinemia and the risk for vascular disease in hemodialysis patients. J Am Soc Nephrol 1995: 6:121-125.
17. Massy ZA. Chadefaux-Vekemans B. Chevalier A, Bader CA, Drueke TB. Legendre C, Lacour B. Kamoun P. Kreis H: Hyperhomocystei-naemia: A significant risk factor for cardiovascular disease in renal transplant recipients. Nephrol Dial Transplant 1994:9:1103-1108.
18. Kim SS, Hirose S. Tamura H, Nagasawa R, Tokushima H, Mitarai T. Isoda K: Hvperho mocysteincmia as a possible role for atherosclerosis in CAPD patients. Adv Perit Dial 1994: 10:282-285.
19. Chauveau P. Chadefaux B, Coude M. Aupctit J, Hannedouche T, Kamoun P,.lungers P: Hv-pcrhomocysteincmia. a risk factor for atherosclerosis in chronic uremic patients. Kidney lnt 1993;43(suppl 41):72-77.
20. Amadottir M. Brattstrom L. Simonscn O. Thy-sell H. Hultberg B, Anderssson A, Nilsson-Ehlc P: The effect of high-dosc pvridoxinc and folic acid supplementation on serum lipid and plasma homocysteine concentrations in dialysis patients. Clin Nephrol 1993:40:236-240.